Jun 04,2024 TOP STORY

Sword Health Introduces Phoenix, the First AI Care Specialist and Raises $130 Million in a Mix of Primary and Secondary Sale

Sword Health has announced a $130 million financing round, raising its total funding to $340 million and valuing the company at $3 billion, a 50% increase from its Series D valuation. This funding round includes primary and secondary sales to provide liquidity to employees and early investors. The company also introduced Phoenix, an AI Care Specialist that offers real-time guidance and feedback to patients during their sessions through natural conversation. Phoenix will first be integrated into Sword's solutions Thrive for physical pain and Bloom for women's pelvic health.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Aug 29,2018

Tempus raises $110M Series E, pushing valuation past $2B

On Wednesday, Tempus announced it has raised a $110 million Series E, which pushes its total funding to $320 million and its valuation to over $2 billion. Participants in the round include existing investors Revolution Growth, New Enterprise Associates and T. Rowe Price, as well as one newcomer, British investment management firm Baillie Gifford. The company has partnered with the American Society of Clinical Oncologists, academic medical centers, National Cancer Institute-designated cancer research centers, hospital networks and local physicians across the country to build the world�s largest library of clinical and molecular cancer data.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
May 06,2019

Wellness Company Noom Raises $58 Million, Led by Sequoia Capital to Grow Its Team and Improve Its Consumer Offering

Noom, the mobile wellness company, has completed a $58 million financing, led by Sequoia Capital. Groupe Arnault's tech arm Aglaé Ventures, Jan Koum, co-founder of WhatsApp, Tony Xu, co-founder of DoorDash, Josh Kushner, co-founder of Oscar Health, Scooter Braun, founder of SB Projects, and existing investor Samsung Ventures have also joined the round. As Noom enters its next stage of growth, the company will use funds from this round to expand the team and improve the customer experience.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
May 06,2019

Noom raises $58M to help you develop healthy habits

Noom, the mobile wellness company, has completed a $58 million financing, led by Sequoia Capital. Groupe Arnault's tech arm Aglaé Ventures, Jan Koum, co-founder of WhatsApp, Tony Xu, co-founder of DoorDash, Josh Kushner, co-founder of Oscar Health, Scooter Braun, founder of SB Projects, and existing investor Samsung Ventures have also joined the round.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Feb 23,2022

Omada Health hits unicorn status with $192M Fidelity-led series E

Omada Health works in that white space, using data-driven personalized care to drive behavioral change. The company just banked $192 million in a series E funding round led by Fidelity, boosting its valuation to over $1 billion, the virtual chronic care management company confirmed to Fierce Healthcare. Fidelity led the series E round with participation from aMoon as well as existing investors Perceptive Advisors, Wellington Management, Civilization Ventures and others.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Apr 11,2018

Livongo gets $105 million, signs deal with insurer Cambia Health Solutions

Digital chronic disease management company Livongo has raised $105 million in new Series E funding. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. Livongo will work with Cambia to roll out its existing diabetes management and hypertension management offerings to Cambia members, and to work with Cambia to create coaching and monitoring platforms for additional chronic conditions.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Feb 23,2022

Omada Health Closes $192 Million Series E Financing to Bring Virtual-First Care to Millions

Omada Health, a chronic care integrated healthcare provider, announced its $192 million Series E funding round led by Fidelity Management & Research Company with participation from aMoon, existing investors Perceptive Advisors, Wellington Management, Civilization Ventures, and others. The company also announced record growth and an expansion of its executive team and Board of Directors with the appointment of Taylor Harris as a new Board member, Nancy Vitale as Chief People Officer and Sunil Kayiti as Chief Technology Officer.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Oct 28,2021

MSK startup Hinge Health lands $600M in new investments

Digital musculoskeletal (MSK) health company Hinge Health has raised a whopping $400 million in a Series E funding round led by Tiger Global and Coatue Management. Alkeon and Whale Rock also put in a $200 million secondary investment to acquire ownership in Hinge. Along with the funding, Hinge also announced two new hires: Lalith Vadlamannati will serve as chief technology officer after spending 13 years at Amazon, and Vincent Lim was hired as chief HR officer, coming from human resources at Google, Medium and JUUL Labs.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Apr 19,2021

Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

Virta Health, the leader in type 2 diabetes reversal, today announced $133 million of equity financing led by Tiger Global. The latest funding round will accelerate Virta's efforts to drive widespread adoption of its telehealth-powered diabetes reversal treatment. Virta helps people reverse their chronic disease while removing the need for costly medications, including insulin.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Oct 25,2022 TOP STORY

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

COTA, Inc., an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management, a healthcare investment firm. Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. In conjunction, COTA announced it has raised additional capital from existing investors. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES E